26 November 2024
|
3
min read
The Financial Times reports on Genomics plc’s latest study, revealing that genetic screening could prevent up to 25% of premature deaths from common diseases such as breast cancer, diabetes, and hypertension. The article highlights the power of polygenic risk scores to identify those most at risk—opening the door for earlier intervention and more targeted prevention.
This article was originally published in The Financial Times.
